Research Article

Evaluation of pressure ulcer development and risk factors in COVID-19 patients followed in the ICU

Volume: 4 Number: 4 August 30, 2023
TR EN

Evaluation of pressure ulcer development and risk factors in COVID-19 patients followed in the ICU

Abstract

Aims: In this study it was aimed to evaluate the causes of pressure ulcer development in COVID-19 patients followed in the intensive care unit (ICU). Methods: Demographic data, comorbidities, laboratory parameters, treatment modalities and mortality rates of the patients were reviewed retrospectively from hospital records. In addition, Acute Physiology and Chronic Health Assessment (APACHE II), Sequential Organ Failure Assessment (SOFA), and modified NUTRIC scores were calculated. Braden scale was used for pressure ulcer evaluation. Results: Eighty COVID-19 patients were included in the study. Pressure ulcers (PU) were detected in 29 (36.25%) of the cases, and no pressure ulcer was detected in 51 (63.75%) cases. 54 (69.7%) of the patients were male, 26 (32.5%) were female, and the mean age was 69 (61-77). The cases were divided into two groups according to the development of pressure ulcers. The APACHE II score was 24 (17-29) in the PU group and 18 (12-23) in the non-PU group (p=0.01), the mNUTRIC score was 4 (3-5) in the PU group and 3 (2-4) in the non-PU group.) (p=0.023), the Braden scale calculated at admission to the ICU was 11(10-13) in the PU group and 14(12-15) (p<0.001) in the non-PU group. A Braden scale score of <13 was found to be 22 (75.9) in the PU group and 14 (27.5) in the non-PU group, and 36 (45) patients in total (p<0.001). Conclusion: The Braden Scale can be used in COVID-19 patients, since they are first admitted to the ICU, both for scoring the wound and predicting the (making a) prognosis quickly.

Keywords

References

  1. (WHO) WHO. Q&A on coronaviruses (COVID-19). Accessed july 6, 2020. https://who.int/news-room/q-a-detail/q-a-coronaviruses
  2. Sun P, Qie S, Liu Z, Ren J, Xi J. Clinical characteristics of 50466 patients with 2019-nCoV infection. MedRxiv. 2020.
  3. Montenegro F, Unigarro L, Paredes G, et al. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review. Exp Rev Respir Med. 2021;15(2):183-195.
  4. Grasselli G, Greco M, Zanella A, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345-1355. doi:10.1001/jamainternmed.2020.3539
  5. WHO. Coronaviruses disease 2019 (COVID-19). 2019; https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  6. Pancorbo-Hidalgo PL, Garcia-Fernandez FP, Lopez-Medina IM, Alvarez-Nieto C. Risk assessment scales for pressure ulcer prevention: a systematic review. J Adv Nurs. 2006;54(1):94-110. doi:10.1111/j.1365-2648.2006.03794.x
  7. Beers MH, Berkow R. The Merck Manual of Geriatrics. Merck & Co. Inc Whitehouse Station, NJ. 2000;
  8. KIRANER E, Hülya K. COVID-19 Tanısı ile yoğun bakımda yatan hastalarda basınç yaralanmalarının ve risk faktörlerinin retrospektif analizi. Yoğun Bakım Hemşireliği Derg. 2021;25(3):139-151.

Details

Primary Language

English

Subjects

Intensive Care

Journal Section

Research Article

Publication Date

August 30, 2023

Submission Date

June 24, 2023

Acceptance Date

July 31, 2023

Published in Issue

Year 2023 Volume: 4 Number: 4

APA
Öner, O., Gürkök, M. Ç., Yakar, M. N., Ergan, B., Yaka, E., & Gökmen, N. (2023). Evaluation of pressure ulcer development and risk factors in COVID-19 patients followed in the ICU. Journal of Medicine and Palliative Care, 4(4), 288-295. https://doi.org/10.47582/jompac.1316995
AMA
1.Öner O, Gürkök MÇ, Yakar MN, Ergan B, Yaka E, Gökmen N. Evaluation of pressure ulcer development and risk factors in COVID-19 patients followed in the ICU. J Med Palliat Care / JOMPAC / jompac. 2023;4(4):288-295. doi:10.47582/jompac.1316995
Chicago
Öner, Ozlemoner, Mehmet Çağatay Gürkök, Mehmet Nuri Yakar, Begüm Ergan, Erdem Yaka, and Necati Gökmen. 2023. “Evaluation of Pressure Ulcer Development and Risk Factors in COVID-19 Patients Followed in the ICU”. Journal of Medicine and Palliative Care 4 (4): 288-95. https://doi.org/10.47582/jompac.1316995.
EndNote
Öner O, Gürkök MÇ, Yakar MN, Ergan B, Yaka E, Gökmen N (August 1, 2023) Evaluation of pressure ulcer development and risk factors in COVID-19 patients followed in the ICU. Journal of Medicine and Palliative Care 4 4 288–295.
IEEE
[1]O. Öner, M. Ç. Gürkök, M. N. Yakar, B. Ergan, E. Yaka, and N. Gökmen, “Evaluation of pressure ulcer development and risk factors in COVID-19 patients followed in the ICU”, J Med Palliat Care / JOMPAC / jompac, vol. 4, no. 4, pp. 288–295, Aug. 2023, doi: 10.47582/jompac.1316995.
ISNAD
Öner, Ozlemoner - Gürkök, Mehmet Çağatay - Yakar, Mehmet Nuri - Ergan, Begüm - Yaka, Erdem - Gökmen, Necati. “Evaluation of Pressure Ulcer Development and Risk Factors in COVID-19 Patients Followed in the ICU”. Journal of Medicine and Palliative Care 4/4 (August 1, 2023): 288-295. https://doi.org/10.47582/jompac.1316995.
JAMA
1.Öner O, Gürkök MÇ, Yakar MN, Ergan B, Yaka E, Gökmen N. Evaluation of pressure ulcer development and risk factors in COVID-19 patients followed in the ICU. J Med Palliat Care / JOMPAC / jompac. 2023;4:288–295.
MLA
Öner, Ozlemoner, et al. “Evaluation of Pressure Ulcer Development and Risk Factors in COVID-19 Patients Followed in the ICU”. Journal of Medicine and Palliative Care, vol. 4, no. 4, Aug. 2023, pp. 288-95, doi:10.47582/jompac.1316995.
Vancouver
1.Ozlemoner Öner, Mehmet Çağatay Gürkök, Mehmet Nuri Yakar, Begüm Ergan, Erdem Yaka, Necati Gökmen. Evaluation of pressure ulcer development and risk factors in COVID-19 patients followed in the ICU. J Med Palliat Care / JOMPAC / jompac. 2023 Aug. 1;4(4):288-95. doi:10.47582/jompac.1316995

TR DİZİN ULAKBİM and International Indexes (1d)

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
 


 

download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiVHJfSW5kZXhfbG9nby5wbmciLCJwYXRoIjoiN2EzMC84NTVhL2UyMWMvNjlkZjRkZmVhNTUyNTYuNzg3NjU2ODgucG5nIiwiZXhwIjoxNzc2MjQ1Nzc0LCJub25jZSI6IjU0MDZkMWE2NmE1Y2QwZTJjNGYyNDA1OTM2MTE0YWIxIn0.Tt-WScFXTj5r2jji5eDMFApNzujLMjMPl8ivXRbozSI



f9ab67f.png
asos-index.png


 


download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiQ3Jvc3NyZWYuanBnIiwicGF0aCI6IjAzMzEvMTdkZi8yN2ZkLzY5ZGY0ZThhMDZkMjg0LjQxMjAyNDg5LmpwZyIsImV4cCI6MTc3NjI0NTkxNCwibm9uY2UiOiI2NjM1Yjc5MWFiY2I1MDQ0NjkzMTAxMDhjY2Y2NzRlMCJ9.5jDQBEY-KErkDK1QjDmv9ichOkNIn5CWYibe1Wz1644
icmje_1_orig.png
 
cc.logo.large.png
 
ncbi.png
 
google-scholar.pngpn6krf5.jpg
 


 

Our journal is in TR-Dizin, DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index, Eurasian Scientific Journal Index (ESJI), and Turkiye Citation Index.

EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation. 

 

Journal articles are evaluated as "Double-Blind Peer Review"